Showing results (31-40 of 540) with videos related to

Sort By:
Pageof 54
Diabetes Care|March 17, 2007
A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patientsJulio Rosenstock, Priscilla Hollander, Kishore M Gadde, et al.
Obesity Research|October 12, 2002
Bupropion SR vs. placebo for weight loss in obese patients with depressive symptomsAdesh K Jain, Roy A Kaplan, Kishore M Gadde, et al.
Current Diabetes Reports|February 8, 2023
Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and TreatmentSabrena F Noria, Rita D Shelby, Katelyn D Atkins, et al.
Updates in Surgery|September 24, 2025
Key genetic determinants of diabetes remission in patients with obesity following bariatric surgeryMaryam Mahjoubin-Tehran, Jonanne Talebloo, Kishore M Gadde, et al.
Obesity (Silver Spring, Md.)|October 19, 2013
Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adultsLouis J Aronne, Thomas A Wadden, Craig Peterson, et al.
The Journal of Clinical Psychiatry|January 27, 2005
The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patientsKathryn M Connor, Victoria M Payne, Kishore M Gadde, et al.
Obesity Research|July 10, 2002
Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trialJames W Anderson, Frank L Greenway, Ken Fujioka, et al.
Plos One|August 14, 2009
Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methodsMai A Elobeid, Miguel A Padilla, Theresa McVie, et al.
BMJ Open|May 14, 2026
How does prior infection and vaccination relate to the risk of incident SARS-CoV-2 infection/reinfection? A prospective cohort study among nine clinical sites in the USA, February 2021 to January 2023Ashley Judge, Erika T Beidelman, David B Allison, et al.
Diabetes Care|May 21, 2021
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b StudyRajaa Nahra, Tao Wang, Kishore M Gadde, et al.
Pageof 54